Phase II randomised trial of raltitrexed–oxaliplatin vs raltitrexed–irinotecan as first-line treatment in advanced colorectal cancer
暂无分享,去创建一个
J. Feliu | A. Pèlegrin | M. González-Barón | J. Castro | P. Escudero | J. Mel | E. Gonzalez | A. Salud | J. Lizón | C. Castañón | L. López-Gómez | M. Ruiz | F. Juárez | E. González | Spain for the Oncopaz Cooperative Group